Granisetron
Composition
Contains Granisetron Hydrochloride, typically 1 mg or 3 mg per dose.
Indications
Prevents and treats nausea and vomiting due to chemotherapy, radiotherapy, and surgery.
Side effects
Headache, constipation, dizziness, fatigue.
Precautions
Use cautiously in patients with cardiac conditions or hepatic impairment.
Contraindications
Hypersensitivity to Granisetron or other 5-HT₃ antagonists.
Dosage and administration
1–2 mg orally or 1 mg IV before chemotherapy; dose varies by route and indication.
Countries
Mexico, Paraguay
Available Forms
Tablets, oral solution, injection (IV), transdermal patch (in some regions).